Benefits Plans - Prescription Drug Plan: Drug Plan Updates and New Drug Releases -
Lipitor Recall

Page last updated: Wednesday, 26-May-2010 20:51:24 EDT

May 27, 2003

The Food and Drug Administration (FDA) announced on May 23, 2003 that Albers Medical Distributors, Inc., has voluntarily recalled three lots of 90-count bottles of the cholesterol-lowering drug Lipitor. The product was repackaged by Med-Pro, Inc., of Lexington, Neb., and the labels say "Repackaged by: MED-PRO, Inc. Lexington, Neb." in the lower left-hand corner. The FDA's investigation into this matter is continuing.

The following repackaged lots are involved in this recall:

  • 20722V - 90-tablet bottles, Expiration 09-2004
  • 04132V - 90-tablet bottles, Expiration 01-2004
  • 16942V - 90-tablet bottles, Expiration 09-2004

AdvancePCS Response

Patients should check the packaging of Lipitor products, filled at retail or mail pharmacies, carefully before using it. Patients who have any of the products (labeled as "Repackaged by MED-PRO, Inc.") with these three lot numbers should not take it, and should return the product to their pharmacies.

AdvanceRx home delivery does not purchase repackaged Lipitor from MedPro, nor do we purchase medications through Albers Medical Distributors; therefore, none of our mail service patients should be affected by this recall. Lipitor is not a specialty medication.

Limitations
The University of Michigan in its sole discretion may modify, amend, or terminate the benefits provided with respect to any individual receiving benefits, including active employees, retirees, and their dependents. Although the university has elected to provide these benefits this year, no individual has a vested right to any of the benefits provided. Nothing in these materials gives any individual the right to continued benefits beyond the time the university modifies, amends, or terminates the benefit. Anyone seeking or accepting any of the benefits provided will be deemed to have accepted the terms of the benefits programs and the university's right to modify, amend or terminate them.